Drug firm Lupin Tuesday said it has launched in the US generic Clomipramine Hydrochloride capsules that are used in treatment of symptoms of obsessive-compulsive disorder.
Clomipramine Hydrochloride capsules USP have been launched in the strengths of 25 mg, 50 mg, and 75 mg after receiving approval for the United States Food and Drug Administration (USFDA) earlier, Lupin said in a filing to BSE.
The product is a generic version of SP ECGX LLC's Anafranil capsules in the same strengths, it added.
The drug is indicated for patients with obsessive-compulsive disorder (OCD) symptoms, Lupin said.
As per IQVIA MAT December 2018 data, Clomipramine Hydrochloride capsules in the three strengths had annual sales of USD 96.2 million in the US, it added.
Shares of Lupin closed at Rs 837.25 per scrip on BSE, down 2.31 per cent from the previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app